CLEARSIDE BIOMEDICAL INC shareholders Q3 2023

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
SIGNATUREFD, LLC 54,177$47,1290.00%
FIRST MANHATTAN CO. LLC. 175,000$152,2320.00%
Stratos Wealth Advisors, LLC 14,000$12,1790.00%
Stratos Wealth Partners, LTD. 31,442$27,3510.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 20,216$17,5860.00%
MORGAN STANLEY 167,772$145,9450.00%
ACADIAN ASSET MANAGEMENT LLC 17,536$150.00%
BlackRock Inc. 763,232$663,9350.00%
Bank of New York Mellon Corp 29,519$25,6790.00%
Cambridge Investment Research Advisors, Inc. 16,500$140.00%
External links

This page lists CLEARSIDE BIOMEDICAL INC's shareholders in Q3 2023. To view CLEARSIDE BIOMEDICAL INC's shareholder history, click here.